Design, synthesis, and evaluation of novel hydrazide and hydroxamate derivatives as potent antileukemic agents with preferential HDAC-2 inhibitory activity over class I isoform
- DOI
- 10.1039/d6ra08049a
- Published
- 2026
- Container
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1039/d6ra08049a,
title = {Design, synthesis, and evaluation of novel hydrazide and hydroxamate derivatives as potent antileukemic agents with preferential HDAC-2 inhibitory activity over class I isoform},
author = {Fatma Elzahraa Ali and Abdullah Yahya Abdullah Alzahrani and Bandar A. Alyami and Stefan Bräse and Anber F. Mohammed and Bahaa G. M. Youssif},
year = {2026},
journal = {RSC Advances},
doi = {10.1039/d6ra08049a},
url = {https://doi.org/10.1039/d6ra08049a}
}RIS
TY - JOUR TI - Design, synthesis, and evaluation of novel hydrazide and hydroxamate derivatives as potent antileukemic agents with preferential HDAC-2 inhibitory activity over class I isoform AU - Fatma Elzahraa Ali AU - Abdullah Yahya Abdullah Alzahrani AU - Bandar A. Alyami AU - Stefan Bräse AU - Anber F. Mohammed AU - Bahaa G. M. Youssif PY - 2026 JO - RSC Advances DO - 10.1039/d6ra08049a UR - https://doi.org/10.1039/d6ra08049a ER -
APA
Ali, F. E., Alzahrani, A. Y. A., Alyami, B. A., Bräse, S., Mohammed, A. F., & Youssif, B. G. M. (2026). Design, synthesis, and evaluation of novel hydrazide and hydroxamate derivatives as potent antileukemic agents with preferential HDAC-2 inhibitory activity over class I isoform. RSC Advances. https://doi.org/10.1039/d6ra08049a
Source records
- crossref · retrieved 2026-11-05T22:03:57.466Z